MULTIFUNCTIONAL MICROFLUIDIC PATCH FOR INFECTIOUS DISEASES DIAGNOSIS

Digital, Industry & SpaceHORIZON-RIAID: 101092049
EC Contribution
€49,861
Consortium Size
9 orgs
Start Year
2023
Summary

In vitro diagnostic (IVD) technologies have revolutionized healthcare, yet remain confined to the laboratories. As witnessed during the COVID-19 pandemic, this traditional centralized approach was not sufficient to prevent and manage viral outbreak because it massively failed to deliver quick and cost-effective diagnosis. The ongoing pandemic further emphasizes the growing need to urgently bring lab-quality diagnosis to the hands of end users (i.e. point-of-care, POC). Despite high expectations from Lab-on-Chip technologies, they failed so far to disrupt the IVD market due to their complexity of integration/operation, high cost, off-chip sample preparation, poor scalability, to mention only a few. The FORTIFIEDx consortium aims to revolutionize the POC IVD field by making use of novel multifunctional biocompatible polymers and their (micro)structuring with mass fabrication technology to develop for the first time a true sample-to-result POC test. We will develop a FORTIFIEDx microfluidic-based patch capable of both biofluids (self-)sampling via hollow microneedles and immediate analysis of this sample on the very same patch in a completely self-powered manner. Two unmet clinical needs, posing epidemic/pandemic treats to both the developed and developing world, are selected: (1) sexually transmitted diseases, in particular simultaneous diagnosis of HIV and Syphilis, to enable timely diagnosis of patients not always able to reach centralized settings due to stigma or financial difficulties and (2) viral haemorrhagic fever, in particular Ebola and Lassa viruses, to battle their highly contagious and deadly outbreaks. To tackle this challenging aim, the interdisciplinary and experienced FORTIFIEDx consortium (2 universities, 5 research institutes and 2 SMEs from 6 countries) will combine insights from material science, engineering and microfabrication, microfluidic technology development, bioassay development, clinical validation and life cycle assessment.

Consortium (9)

Project Results (10)

Source: CORDIS, the EU research results database.

Publications (4)
Multimaterial Digital Light Processing Three-Dimensional Printing of Materials with Different Relaxation Kinetics
ACS Applied Polymer Materials· 2025DOI
Roman Korotkov, Milena Gleirscher, Sandra Schlögl, Elisabeth Rossegger
Chick embryo sexing ‘simple-fied’ with a sample-in-result-out rpa lab-on-a-chip platform
· 2024
Monteiro Belo dos Santos, Simão; Vloemans, Dries; Wegsteen, Celine; Spasic, Dragana; Lammertyn, Jeroen
Fully automated sample-to-result SIMPLE-RPA microfluidic chip: towards in ovo sexing application
npj Biosensing· 2024DOI
Simão Monteiro Belo dos Santos; Celine Wegsteen; Dries Vloemans; Matthias Corion; Bart De Ketelaere; Dragana Spasic; Jeroen Lammertyn
Revolutionizing sample preparation: a novel autonomous microfluidic platform for serial dilution
Lab on a Chip· 2024DOI
Dries Vloemans; Alexander Pieters; Francesco Dal Dosso; Jeroen Lammertyn
Deliverables (5)
Websites, patent fillings, videos etc.
Data Management Plan
Websites, patent fillings, videos etc.
Websites, patent fillings, videos etc.
Other Results (1)
Periodic Reporting for period 1 - FORTIFIEDx (MULTIFUNCTIONAL MICROFLUIDIC PATCH FOR INFECTIOUS DISEASES DIAGNOSIS)